When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Thinly traded nano cap Mereo BioPharma Group (MREO+27.1%) is up more than double normal volume, albeit on turnover of only 465K shares, on the heels of its out-licensing agreement with Oncologie for exclusive global rights to ovarian cancer candidate navicixizumab, one of two assets Merel acquired via its reverse merger with OncoMed Pharmaceuticals last year.
More news on: Mereo BioPharma Group plc, Healthcare stocks news, Stocks on the move,